|Publication number||US4500676 A|
|Application number||US 06/561,816|
|Publication date||Feb 19, 1985|
|Filing date||Dec 15, 1983|
|Priority date||Dec 15, 1983|
|Also published as||CA1218776A, CA1218776A1, DE3434042A1, DE3434042C2|
|Publication number||06561816, 561816, US 4500676 A, US 4500676A, US-A-4500676, US4500676 A, US4500676A|
|Inventors||Endre A. Balazs, Adolf Leshchiner|
|Original Assignee||Biomatrix, Inc.|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (3), Referenced by (155), Classifications (45), Legal Events (10)|
|External Links: USPTO, USPTO Assignment, Espacenet|
1. Field of the Invention
The present invention relates to polymeric articles modified with hyaluronic acid ("HA"), and having improved biocompatibility which enables the modified articles to be used in numerous in vivo applications, such as various prosthetic devices including artificial heart valves, vascular grafts, etc.
2. The Prior Art
Hyaluronic acid is a known, naturally occurring material which has many applications in medicine and biology. See, for example, E. A. Balazs U.S. Pat. No. 4,272,522 and publications cited therein.
The present invention is directed to polymeric articles modified with hyaluronic acid (a substance which is normally present in animal tissues) so as to confer on such articles a considerably higher degree of biocompatibility than the unmodified articles. The invention includes polymeric articles such as castings, films, fibers and fabrics which contain hyaluronic acid or salts thereof dispersed throughout the article or as a coating on the surface thereof, or both. The hyaluronic acid may also be cross-linked after preparation of the article. The thusly modified polymeric articles are therefore quite suitable for use in various prosthetic devices such as artificial heart valves, intraocular lenses, vascular grafts, pacemaker leads and the like, as well as in various kinds of drug delivery systems.
The polymers which can be modified with hyaluronic acid in accordance with the invention are quite numerous and include:
(1) polyurethanes, including aliphatic, aromatic and araliphatic polyetherurethanes and polyesterurethanes
(2) polyolefins such as polyethylene;
(3) vinyl polymers such as polyvinyl chloride, polyvinyl alcohol and polyvinyl acetate and copolymers thereof;
(4) acrylic polymers such as poly (hydroxyethyl) methacrylate and copolymers of methyl acrylate and methyl methacrylate;
(6) polyesters; and
There are numerous methods of introducing the hyaluronic acid into a polymer or applying it onto the surface of a polymer. One method involves dissolving hyaluronic acid in an appropriate solvent and mixing the obtained solution with a polymer solution or an emulsion and thereafter forming an article, for example a film, from the mixture or applying this mixture as a coating. The suitable solvents for dissolving hyaluronic acid are water, dimethylsulfoxide and dimethylformamide. The surface of the polymeric substrate may be activated, as can the hyaluronic acid.
Another method involves adding hyaluronic acid in a solid form, preferably as a powder, to a polymer solution and thereafter forming an article, for example a film, from the obtained mixture or applying this mixture as a coating.
Still another method involves coating a particulate material with hyaluronic acid from solution and introducing the coated particles into a polymer solution and then forming an article, for example a film, from the obtained mixture or applying this mixture as a coating. Examples of suitable particulate materials are ion exchange resins, silica, alumina, etc.
Finally, in any of the methods described above, the hyaluronic acid can be cross-linked before or after mixing with the polymer with the use of various cross-linking agents.
The following examples (wherein all parts given are by weight unless otherwise specified) illustrate the several embodiments of the invention, without however being a limitation thereof, the invention being solely defined by the claims.
In Examples 1-4, improved polyurethane articles were prepared which consist of a layer of polyurethane and one or two layers of an elastic film-forming mixture of hyaluronic acid with another polymer or polymers.
A piece of polyetherurethane rubber film (Upjohn) was activated by dipping in a dimethylformamide bath for 10 seconds and following washing with a water/acetone mixture of 1:30 by volume for one minute and then with water for one minute.
A mixture containing hyaluronic acid was prepared in the following manner: 31.0 g of a 1% water solution of the sodium salt of hyaluronic acid (prepared from rooster combs, protein content 1.15%, intrinsic viscosity [n] 2,700) was diluted with 60.0 g of water and then mixed with 6.7 g of an aliphatic polyurethane water emulsion (Neo Rez R962, Polyvinyl Chemical Industries). A translucent, moderately viscous mixture was obtained, solid content 2.96%, hyaluronic acid/polyurethane ratio was about 1:4. The activated polyurethane film was dipped into the prepared mixture, then dried in air for 30 minutes and, finally, in a vacuum oven at 55° C. and 43 mm Hg for 30 minutes. The obtained article consisted of a layer of the polyetherurethane rubber film coated from both sides with a continuous film consisting of the aliphatic polyurethane and sodium hyaluronate.
The procedure described in Example 1 was repeated with the exception that 0.3 g of a polyfunctional azirdine compound (Polyvinyl Chemical Industries, cross-linker CX-100) was added. The obtained article consisted of a layer of the polyetherurethane rubber film coated from both sides with a continuous film consisting of an aliphatic polyetherurethane and cross-linked sodium hyaluronate.
A glass rod was coated by dipping it into a 10% solution of a polyetherurethane (The Upjohn Company, Pellethane 80 AE) in dimethylformamide. The polymer film was coagulated in water/acetone mixture of 3:1 by volume. The film on the rod was dried in an oven at 80° C. for 30 minutes. The second layer was applied by dipping into the polyurethane-sodium hyaluronate mixture according to Example 1.
The obtained tubular article consisted of two layers, one of which was a polyetherurethane film and the second one a mixed film from an aliphatic polyurethane and cross-linked sodium hyaluronate.
1.09 g of air dried sodium hyaluronate was dissolved in a mixture of 4.40 g of water and 67 g of dimethylformamide. 10 g of the resulting solution were mixed with 10 g of a 25% solution of a polyetherurethane (Upjohn Company, Pellethane 80 AE) in dimethylacetamide. Solid content in this solution was 13.66% with sodium hyaluronate/polyurethane ratio of 1:40. A glass rod was dipped into this viscous solution. The polymers were coagulated in a water/acetone=3:1 by volume mixture. The tubular film was washed in water 10 minutes and then dried off in a vacuum oven at 45 mm Hg and 50° C. for 45 minutes.
The following examples illustrate the application of a hyaluronic acid coating onto a polyester fabric (Example 5) and onto a PVC film (Example 6)
A solution containing 1.5% by weight of hyaluronic acid and 1.0% by weight of cross-linking agent CX-100 was prepared. A piece of Dacron knitted fabric was dipped into the solution for 2 minutes. The excess of the solution was squeezed off and the sample was dried overnight. The hyaluronic acid content in the coated fabric was 3.7% by weight.
A water solution of sodium hyaluronate was added to a vinyl acrylic water emulsion (Amsco-Res 9205, Union Chemicals Division) to obtain a mixture containing 0.25% by weight of hyaluronic acid. The mixture was applied by dipping onto polyvinyl chloride (PVC) film and dried in air for 2 hours. The coated film was treated in 1% by weight solution of cross-linking agent CX-100 in a water-acetone mixture containing 20% by volume of acetone and dried in air for 3 hours. A film with a well adhered coating containing hyaluronic acid was obtained.
The following examples illustrate another approach to obtaining a polyurethane film containing sodium hyaluronate, namely, introducing sodium hyaluronate in a finely divided powder form into a polyurethane solution (followed by casting the mixture) and precipitating the film by the appropriate coagulating medium.
Sodium hyaluronate (0.33 g; intrinsic viscosity 3,160) in a finely divided powder form was added to 10.69 g of polyurethane (Pellethane 80AE, Upjohn Company) solution in dimethylacetamide (concentration 16.4% by weight). The mixture was spread on a glass plate with the aid of a glass rod and put into 100 ml of 95% ethyl alcohol. The precipitated, milky-white film was left in the alcohol for 10 minutes, then removed from the bath, washed twice with ethanol and dried in air. The obtained elastic film contained 9.35% by weight sodium hyaluronate.
The following example illustrates the modification of the film obtained as described above in Example 7 which leads to the formation of a cross-linked hyaluronic acid layer on the surface of the film. The treatment consists in putting the film into a water solution of the cross-linking agent which cross-links hyaluronic acid upon drying. In this treatment, hyaluronic acid particles swell and partially dissolve in water and migrate to the surface of the film. As a result, there is a layer of a concentrated hyaluronic acid solution on the surface. Upon drying, hyaluronic acid is cross-linked by the cross-linking agent and, in this way, a layer of cross-linked hyaluronic acid is formed on the film surface.
The film obtained in Example 7 was dipped into a solution of polyfunctional arizidine compound in water (0.5% by weight; cross-linker, CX-100, Polyvinyl Chemical Industries) for 1 minute, then removed from the solution and dried in air for 2 hours. Then the film was washed repeatedly in water and dried. The film obtained had a continuous layer of cross-linked hyaluronic acid on its surface which was proven by staining the film in a water solution of Toluidine On Blue.
The following example illustrates a variant of the approach described above. In this variant, a material consisting of small particles, e.g., ion exchange resin, silica, alumina, etc., is coated with hyaluronic acid, and these coated particles are introduced into a polyurethane.
An ion exchange resin (5.0 g of Dowex 50W-2x, mesh size 200-400) was mixed with 10.6 g of hyaluronic acid in water at a concentration 7.2 mg/ml. The mixture was dried in a vacuum oven. The product obtained contained 1.5% hyaluronic acid. The coated resin (0.5 g) was mixed with 5 g of the polyurethane solution used in the preceding example. The film was precipitated and treated as above. The hyaluronic acid content in the film was 0.38%.
The following example illustrates modification of the surface properties of silicone rubber with a hyaluronate containing coating.
A piece of a silicone rubber (Silastic, Dow Corning) was dipped into a 10% solution of an amine-containing silane (Silane A-1100, Union Carbide) in toluene, dried 10 minutes in air and then in an oven at 60° C. for 10 minutes. Thus treated rubber was dipped into a solution containing 0.5% of sodium hyaluronate and 0.12% of cross-linker CX-100. The sample was dried in air and then in an oven at 70° C. for 10 minutes. The modified sample had a wettable surface. This property was permanent as was found by repeatedly washing the sample with water.
The biocompatibility of the preparations according to the invention was demonstrated by the test hereafter described.
Release of 3 H-serotonin by human platelets was used in preliminary studies to assess the blood reactivity of the product of Example 5. Normal human venous blood was drawn into plastic syringes and immediately transferred to plastic tubes containing 3.8% sodium citrate (one part citrate to nine parts whole blood). Platelet rich plasma was prepared by centrifugation at 4° C. for 15 minutes at 125×g and removed by serological pipet to a plastic or siliconized test tube. 3 H-serotonin (3 H-5-hydroxytryptamine, 3 H-5HT; New England Nuclear, 26.3 Ci/mmol, 1 mCi/ml ethanol-water) was added to platelet rich plasma (PRP), 0.2-0.5 ul/ml PRP, and incubated for 15 minutes at 37° C. In the assay, siliconized or polypropylene test tubes were used; thrombin was used as a positive control, coated and uncoated samples were tested. 1.0-2.0 ml of 3 H-5HT-PRP was added to each of duplicate tubes containing samples to be assayed; a 50 ul aliquot was removed from the control mixture for determination of total radioactivity. Following the appropriate incubation period (10-120 minutes) 0.2-0.5 ml aliquots of the suspension were removed and centrifuged over silicon oil in an Eppendorf microfuge for two minutes at 12,000×g. 50 ul of the supernatant was removed from each tube, mixed with 5 ml of liquid scintillation fluid, and radioactivity measured by beta-spectrometry. The amount of 3 H-5HT released by thrombin or the test samples was the increment in radioactivity of the supernatant (radioactivity of experimental samples minus radioactivity control). Coated samples of the product of example 5 were consistently less reactive in terms of amount of 3 H-5HT released; uncoated samples induced 52% greater release than the coated samples.
Variations and modifications can, of course, be made without departing from the spirit and scope of the invention.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US4272522 *||Oct 15, 1979||Jun 9, 1981||Balazs Endre A||Method for stimulating phagocytic activity and synergistic compositions therefor|
|US4349467 *||Sep 17, 1979||Sep 14, 1982||Williams Joel L||Nonthrombogenic articles and method of preparation|
|US4415490 *||Jul 24, 1979||Nov 15, 1983||Nippon Zeon Co., Ltd.||Non-thrombogenic material|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US4582865 *||Dec 6, 1984||Apr 15, 1986||Biomatrix, Inc.||Cross-linked gels of hyaluronic acid and products containing such gels|
|US4605691 *||Jul 18, 1985||Aug 12, 1986||Biomatrix, Inc.||Cross-linked gels of hyaluronic acid and products containing such gels|
|US4636524 *||Mar 8, 1985||Jan 13, 1987||Biomatrix, Inc.||Cross-linked gels of hyaluronic acid and products containing such gels|
|US4663233 *||Oct 24, 1985||May 5, 1987||Universal High Technologies||Lens with hydrophilic coating|
|US4713448 *||Mar 12, 1985||Dec 15, 1987||Biomatrix, Inc.||Chemically modified hyaluronic acid preparation and method of recovery thereof from animal tissues|
|US4801475 *||Aug 23, 1984||Jan 31, 1989||Gregory Halpern||Method of hydrophilic coating of plastics|
|US4822615 *||Sep 9, 1986||Apr 18, 1989||Sumitomo Electric Industries, Ltd.||Antithrombic resin composition|
|US4957744 *||Oct 13, 1987||Sep 18, 1990||Fidia, S.P.A.||Cross-linked esters of hyaluronic acid|
|US4973493 *||Oct 15, 1987||Nov 27, 1990||Bio-Metric Systems, Inc.||Method of improving the biocompatibility of solid surfaces|
|US4979959 *||May 5, 1989||Dec 25, 1990||Bio-Metric Systems, Inc.||Biocompatible coating for solid surfaces|
|US4988503 *||Jan 24, 1990||Jan 29, 1991||Revlon, Inc.||Oil-in-water emulsions for foundation makeup composition|
|US5023114 *||May 2, 1990||Jun 11, 1991||Gregory Halpern||Method of hydrophilic coating of plastics|
|US5037677 *||Nov 7, 1989||Aug 6, 1991||Gregory Halpern||Method of interlaminar grafting of coatings|
|US5041100 *||Apr 28, 1989||Aug 20, 1991||Cordis Corporation||Catheter and hydrophilic, friction-reducing coating thereon|
|US5099013 *||Nov 16, 1990||Mar 24, 1992||Biomatrix, Inc,||Hylan preparation and method of recovery thereof from animal tissues|
|US5128326 *||Jul 23, 1990||Jul 7, 1992||Biomatrix, Inc.||Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same|
|US5182317 *||Jun 17, 1991||Jan 26, 1993||Cardiopulmonics, Inc.||Multifunctional thrombo-resistant coatings and methods of manufacture|
|US5217492 *||Apr 3, 1991||Jun 8, 1993||Bio-Metric Systems, Inc.||Biomolecule attachment to hydrophobic surfaces|
|US5219360 *||May 10, 1991||Jun 15, 1993||Fortis Research Corporation||Mammary prosthesis fill and method of making same|
|US5258041 *||Mar 19, 1991||Nov 2, 1993||Bio-Metric Systems, Inc.||Method of biomolecule attachment to hydrophobic surfaces|
|US5262451 *||Jul 5, 1988||Nov 16, 1993||Cardiopulmonics, Inc.||Multifunctional thrombo-resistant coatings and methods of manufacture|
|US5263992 *||Oct 24, 1991||Nov 23, 1993||Bio-Metric Systems, Inc.||Biocompatible device with covalently bonded biocompatible agent|
|US5264207 *||Jul 17, 1990||Nov 23, 1993||Exsymol S.A.M.||Products for cutaneous applications with cosmetic and/or therapeutic effects|
|US5264422 *||Jun 20, 1991||Nov 23, 1993||Fidia S.P.A.||Esters of alginic acid with steroidal alcohols|
|US5322659 *||Sep 21, 1990||Jun 21, 1994||Becton, Dickinson And Company||Method for rendering a substrate surface antithrombogenic and/or anti-infective|
|US5324775 *||Jul 2, 1992||Jun 28, 1994||Collagen Corporation||Biologically inert, biocompatible-polymer conjugates|
|US5336668 *||Jun 20, 1991||Aug 9, 1994||Fidia, S.P.A.||Esters of alginic acid|
|US5342693 *||Mar 22, 1993||Aug 30, 1994||Cardiopulmonics, Inc.||Multifunctional thrombo-resistant coating and methods of manufacture|
|US5356629 *||Jul 12, 1991||Oct 18, 1994||United States Surgical Corporation||Composition for effecting bone repair|
|US5391203 *||Apr 13, 1992||Feb 21, 1995||Scott P. Bartlett||Method of draining and filling soft tissue implant|
|US5416205 *||Nov 22, 1993||May 16, 1995||Fidia, S.P.A.||New esters of alginic acid|
|US5442053 *||Aug 19, 1992||Aug 15, 1995||Fidia, S.P.A.||Salts and mixtures of hyaluronic acid with pharmaceutically active substances, pharmaceutical compositions containing the same and methods for administration of such compositions|
|US5512329 *||Dec 27, 1993||Apr 30, 1996||Bsi Corporation||Substrate surface preparation|
|US5616568 *||Nov 30, 1993||Apr 1, 1997||The Research Foundation Of State University Of New York||Functionalized derivatives of hyaluronic acid|
|US5631241 *||Apr 21, 1995||May 20, 1997||Fidia S.P.A.||Pharmaceutical compositions containing hyaluronic acid fractions|
|US5652347 *||Jun 7, 1995||Jul 29, 1997||The Research Foundation Of State University Of New York||Method for making functionalized derivatives of hyaluronic acid|
|US5690961 *||Dec 22, 1994||Nov 25, 1997||Hercules Incorporated||Acidic polysaccharides crosslinked with polycarboxylic acids and their uses|
|US5700479 *||Nov 10, 1994||Dec 23, 1997||Guidor Ab||Surgical element and method for selective tissue regeneration|
|US5713959 *||Dec 20, 1994||Feb 3, 1998||Scott P. Bartlett||Soft tissue implants|
|US5741551 *||Apr 23, 1996||Apr 21, 1998||Bsi Corporation||Preparation of polymeric surfaces|
|US5767106 *||Aug 25, 1994||Jun 16, 1998||Hyal Pharmaceutical Corporation||Treatment of disease and conditions associated with macrophage infiltration|
|US5792753 *||Feb 17, 1993||Aug 11, 1998||Hyal Pharmaceutical Corporation||Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs|
|US5795584 *||Feb 7, 1995||Aug 18, 1998||United States Surgical Corporation||Post-surgical anti-adhesion device|
|US5824658 *||Aug 7, 1995||Oct 20, 1998||Hyal Pharmaceutical Corporation||Topical composition containing hyaluronic acid and NSAIDS|
|US5869127 *||Jun 18, 1997||Feb 9, 1999||Boston Scientific Corporation||Method of providing a substrate with a bio-active/biocompatible coating|
|US5899890 *||Jun 21, 1996||May 4, 1999||Medtronic, Inc.||Flow-directed catheter system and method of use|
|US5910489 *||Feb 16, 1993||Jun 8, 1999||Hyal Pharmaceutical Corporation||Topical composition containing hyaluronic acid and NSAIDS|
|US5962433 *||Jun 6, 1995||Oct 5, 1999||Hyal Pharmaceutical Corporation||Topical composition containing hyaluronic acid and NSAIDS|
|US5977088 *||Jun 6, 1995||Nov 2, 1999||Hyal Pharmaceutical Corporation||Formulations containing hyaluronic acid|
|US5990096 *||Jun 6, 1995||Nov 23, 1999||Hyal Pharmaceutical Corporation||Formulations containing hyaluronic acid|
|US6099563 *||Dec 11, 1998||Aug 8, 2000||Boston Scientific Corporation||Substrates, particularly medical devices, provided with bio-active/biocompatible coatings|
|US6103704 *||Feb 17, 1993||Aug 15, 2000||Hyal Pharmaceutical Corporation||Therapeutic methods using hyaluronic acid|
|US6140312 *||Jun 6, 1995||Oct 31, 2000||Hyal Pharmaceutical Corporation||Formulations containing hyaluronic acid|
|US6160032 *||Sep 30, 1998||Dec 12, 2000||Medtronic Ave, Inc.||Biocompatible coating composition|
|US6179817||Jan 28, 1999||Jan 30, 2001||Boston Scientific Corporation||Hybrid coating for medical devices|
|US6218373||Jun 6, 1995||Apr 17, 2001||Hyal Pharmaceutical Corporation||Formulations containing hyaluronic acid|
|US6221059||Apr 21, 1999||Apr 24, 2001||Medtronic, Inc.||Flow-directed catheter system and method of use|
|US6264702 *||Jul 22, 1998||Jul 24, 2001||Sofradim Production||Composite prosthesis for preventing post-surgical adhesions|
|US6387450||Nov 9, 2000||May 14, 2002||Medtronic Ave, Inc.||Method for preparing a biocompatible coating|
|US6428903 *||Apr 14, 1998||Aug 6, 2002||Fidia Advanced Biopolymers S.R.L.||Coatings based on hyaluronic acid and the derivatives thereof for the protection of electronic parts from external agents|
|US6506411||Apr 19, 1999||Jan 14, 2003||Angiotech Pharmaceuticals, Inc.||Anti-angiogenic compositions and methods of use|
|US6511507||May 10, 2002||Jan 28, 2003||Medtronic Ave Inc.||Article with biocompatible coating|
|US6537283||Aug 17, 2001||Mar 25, 2003||Alcon, Inc.||Intraocular lens shipping case and injection cartridge|
|US6709706||Mar 14, 2003||Mar 23, 2004||Scimed Life Systems, Inc.||Hydrophilic coating and substrates coated therewith having enhanced durablity and lubricity|
|US6939530 *||Jun 21, 2002||Sep 6, 2005||Quadrant Drug Delivery Limited||Preparation of further diagnostic agents|
|US6951894||Aug 17, 2000||Oct 4, 2005||Ciba Vision Corporation||Extended wear ophthalmic lens|
|US7345117 *||Feb 24, 1999||Mar 18, 2008||Rolando Barbucci||Sulphated hyaluronic acid and sulphated derivatives thereof covalently bound to polyurethanes, and the process for their preparation|
|US7348038||Dec 16, 2003||Mar 25, 2008||Advanced Medical Optics, Inc.||IOL insertion apparatus and method for making and using same|
|US7468398||Jun 7, 2005||Dec 23, 2008||Ciba Vision Corporation||Extended wear ophthalmic lens|
|US7538146||Dec 30, 2006||May 26, 2009||Ciba Vision Corporation||Extended wear ophthalmic lens|
|US7553880||Dec 30, 2006||Jun 30, 2009||Ciba Vision Corporation||Extended wear ophthalmic lens|
|US7857849 *||Oct 4, 2005||Dec 28, 2010||The Board Of Trustees Of The Leland Stanford Junior Iniversity||Artificial corneal implant|
|US8021350||Jan 29, 2009||Sep 20, 2011||The Cleveland Clinic Foundation||Hydroxyphenyl cross-linked macromolecular network and applications thereof|
|US8080028||Dec 5, 2005||Dec 20, 2011||Novartis Ag||Surgical device includes an anti-microbial coating|
|US8080260||Feb 13, 2009||Dec 20, 2011||The Cleveland Clinic Foundation||Molecular enhancement of extracellular matrix and methods of use|
|US8137688||Feb 27, 2009||Mar 20, 2012||The Cleveland Clinic Foundation||Hydroxyphenyl cross-linked macromolecular network and applications thereof|
|US8138265||Jan 29, 2009||Mar 20, 2012||The Cleveland Clinic Foundation||Hydroxyphenyl cross-linked macromolecular network and applications thereof|
|US8207262||Sep 15, 2008||Jun 26, 2012||The Cleveland Clinic Foundation||Hydroxyphenyl cross-linked macromolecular network and applications thereof|
|US8257727||Jul 14, 2006||Sep 4, 2012||Fmc Biopolymer As||Medical devices coated with a fast dissolving biocompatible coating|
|US8278406||Apr 25, 2008||Oct 2, 2012||Wisconsin Alumni Research Foundation||Bioactive and biocompatible polyurethane-buthanediol-glycosaminoglycan salt copolymers|
|US8313760||Apr 22, 2008||Nov 20, 2012||Angiotech International Ag||Compositions and methods for coating medical implants|
|US8372420||Sep 3, 2009||Feb 12, 2013||Angiotech International Ag||Compositions and methods for coating medical implants|
|US8410180||Apr 30, 2009||Apr 2, 2013||The Cleveland Clinic Foundation||Methods to treat urinary incontinence|
|US8415404||Jun 4, 2010||Apr 9, 2013||Ciba Vision Corporation||Extended wear ophthalmic lens|
|US8425541||Apr 25, 2008||Apr 23, 2013||Wisconsin Alumni Research Foundation||Aneurysm occlusion device containing bioactive and biocompatible copolymer shell and a liquid embolic agent|
|US8425542||Apr 25, 2008||Apr 23, 2013||Wisconsin Alumni Research Foundation||Aneurysm occlusion device containing bioactive and biocompatible copolymer shell and biocompatible metallic frame member|
|US8425927||Nov 4, 2010||Apr 23, 2013||Angiotech International Ag||Compositions and methods for coating medical implants|
|US8497023||Aug 5, 2009||Jul 30, 2013||Biomimedica, Inc.||Polyurethane-grafted hydrogels|
|US8568626||Oct 16, 2008||Oct 29, 2013||Ciba Vision Corporation||Extended wear ophthalmic lens|
|US8679190||Mar 12, 2012||Mar 25, 2014||The Board Of Trustees Of The Leland Stanford Junior University||Hydrogel arthroplasty device|
|US8822551||Mar 22, 2013||Sep 2, 2014||Genewel Co., Ltd.||Implantation material comprising biocompatible polymer|
|US8853294||May 29, 2013||Oct 7, 2014||Biomimedica, Inc.||Polyurethane-grafted hydrogels|
|US8883915||Aug 26, 2011||Nov 11, 2014||Biomimedica, Inc.||Hydrophobic and hydrophilic interpenetrating polymer networks derived from hydrophobic polymers and methods of preparing the same|
|US9011888 *||Jul 30, 2010||Apr 21, 2015||Jgc Catalysts And Chemicals Ltd.||Organic-inorganic composite particles, process for producing the same, dispersion containing the particles, and cosmetic containing the particles|
|US9114024||Nov 21, 2012||Aug 25, 2015||Biomimedica, Inc.||Systems, devices, and methods for anchoring orthopaedic implants to bone|
|US9228027||Sep 2, 2009||Jan 5, 2016||Allergan Holdings France S.A.S.||Threads of Hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof|
|US9242026||Jun 26, 2009||Jan 26, 2016||Sofradim Production||Biosynthetic implant for soft tissue repair|
|US20030133876 *||Jun 21, 2002||Jul 17, 2003||Quadrant Healthcare (Uk) Limited, A Member Of The Elam Group Of Companies||Preparation of further diagnostic agents|
|US20030175354 *||Mar 18, 2003||Sep 18, 2003||L.A.M. Pharmaceutical Corporation||Antiemetic, anti-motion sustained release drug delivery system|
|US20030216758 *||Dec 27, 2002||Nov 20, 2003||Angiotech Pharmaceuticals, Inc.||Coated surgical patches|
|US20040043052 *||May 27, 2003||Mar 4, 2004||Angiotech Pharmaceuticals, Inc.||Compositions and methods for coating medical implants|
|US20040133212 *||Dec 16, 2003||Jul 8, 2004||Harish Makker||IOL insertion apparatus and method for making and using same|
|US20050182450 *||Dec 7, 2004||Aug 18, 2005||Angiotech International Ag||Electrical devices and anti-scarring agents|
|US20050182467 *||Dec 7, 2004||Aug 18, 2005||Angiotech International Ag||Electrical devices and anti-scarring agents|
|US20050182468 *||Dec 7, 2004||Aug 18, 2005||Angiotech International Ag||Electrical devices and anti-scarring agents|
|US20050187600 *||Nov 26, 2004||Aug 25, 2005||Angiotech International Ag||Electrical devices and anti-scarring agents|
|US20050192647 *||Dec 7, 2004||Sep 1, 2005||Angiotech International Ag||Electrical devices and anti-scarring agents|
|US20050220837 *||Sep 30, 2004||Oct 6, 2005||Disegi John A||Antimicrobial hyaluronic acid coatings for orthopedic implants|
|US20050228065 *||Jun 7, 2005||Oct 13, 2005||Ciba Vision Corporation||Extended wear ophthalmic lens|
|US20060083773 *||Oct 4, 2005||Apr 20, 2006||David Myung||Artificial corneal implant|
|US20060094643 *||Jul 3, 2003||May 4, 2006||Yuri Svirkin||Compositions of hyaluronic acid and methods of use|
|US20060127438 *||Jan 31, 2006||Jun 15, 2006||Angiotech International Ag||Compositions and methods for coating medical implants|
|US20060282123 *||Dec 7, 2004||Dec 14, 2006||Angiotech International Ag||Electrical devices and anti-scarring agents|
|US20070077271 *||Jul 14, 2006||Apr 5, 2007||Michael Dornish||Medical devices coated with a fast dissolving biocompatible coating|
|US20070129743 *||Dec 5, 2005||Jun 7, 2007||Alcon, Inc.||Surgical device|
|US20070203502 *||Apr 5, 2007||Aug 30, 2007||Advanced Medical Optics, Inc.||Iol insertion apparatus and method for making and using same|
|US20070270447 *||Jul 31, 2007||Nov 22, 2007||Angiotech International Ag||Compositions and methods for coating medical implants|
|US20080089952 *||Jul 31, 2007||Apr 17, 2008||Angiotech International Ag||Compositions and methods for coating medical implants|
|US20080113000 *||Jul 31, 2007||May 15, 2008||Angiotech International Ag||Compositions and methods for coating medical implants|
|US20080145514 *||Jul 31, 2007||Jun 19, 2008||Angiotech International Ag||Compositions and methods for coating medical implants|
|US20080191103 *||Feb 10, 2006||Aug 14, 2008||Lorne Thurgar||Clip|
|US20080241217 *||Feb 22, 2008||Oct 2, 2008||Angiotech International Ag||Compositions and methods for coating medical implants|
|US20080293906 *||Apr 25, 2008||Nov 27, 2008||Wisconsin Alumni Research Foundation||Bioactive and biocompatible polyurethane-buthanediol-glycosaminoglycan salt copolymers|
|US20090042294 *||Sep 15, 2008||Feb 12, 2009||The Cleveland Clinic Foundation||Hydroxyphenyl cross-linked macromolecular network and applications thereof|
|US20090046242 *||Oct 16, 2008||Feb 19, 2009||Ciba Vision Corporation||Extended Wear Ophthalmic Lens|
|US20090060973 *||Apr 22, 2008||Mar 5, 2009||Angiotech International Ag||Compositions and methods for coating medical implants|
|US20090062834 *||Apr 25, 2008||Mar 5, 2009||Wisconsin Alumni Research Foundation||Aneurysm occlusion device containing bioactive and biocompatible copolymer shell and biocompatible metallic frame member|
|US20090118761 *||Apr 25, 2008||May 7, 2009||Wisconsin Alumni Research Foundation||Aneurysm occlusion device containing bioactive and biocompatible copolymer shell and a liquid embolic agent|
|US20090142309 *||Jan 29, 2009||Jun 4, 2009||The Cleveland Clinic Foundation||Hydroxyphenyl cross-linked macromolecular network and applications thereof|
|US20090143766 *||Jan 29, 2009||Jun 4, 2009||The Cleveland Clinic Foundation||Hydroxyphenyl cross-linked macromolecular network and applications thereof|
|US20090192532 *||Jul 30, 2009||Linda Spinnler||Implant for parastomal hernia|
|US20090240337 *||Mar 23, 2009||Sep 24, 2009||David Myung||Methods, Devices and Compositions for Adhering Hydrated Polymer Implants to Bone|
|US20090252700 *||Feb 27, 2009||Oct 8, 2009||The Cleveland Clinic Foundation||Hydroxyphenyl cross-linked macromolecular network and applications thereof|
|US20090274678 *||Nov 5, 2009||The Cleveland Clinic Foundation||Compositions and methods to treat urinary incontinence|
|US20100010114 *||Jul 7, 2009||Jan 14, 2010||David Myung||Hydrophilic Interpenetrating Polymer Networks Derived From Hydrophobic Polymers|
|US20100015868 *||Jan 21, 2010||Philippe Gravagna||Reinforced composite implant|
|US20100016872 *||Jan 21, 2010||Yves Bayon||Biosynthetic implant for soft tissue repair|
|US20100238398 *||Jun 4, 2010||Sep 23, 2010||Ciba Vision Corporation||Extended Wear Ophthalmic Lens|
|US20100268288 *||Feb 10, 2010||Oct 21, 2010||Angiotech International Ag||Electrical devices and anti-scarring agents|
|US20110129513 *||Nov 4, 2010||Jun 2, 2011||Angiotech International Ag||Compositions and methods for coating medical implants|
|US20110152868 *||Dec 20, 2010||Jun 23, 2011||Lampros Kourtis||Method, device, and system for shaving and shaping of a joint|
|US20120128748 *||Jul 30, 2010||May 24, 2012||Jgc Catalysts And Chemicals Ltd.||Organic-Inorganic Composite Particles, Process for Producing the Same, Dispersion Containing the Particles, and Cosmetic Containing the Particles|
|US20140074224 *||Nov 15, 2013||Mar 13, 2014||Abbott Cardiovascular Systems Inc.||Coating of fast absorption or dissolution|
|DE19630879A1 *||Jul 31, 1996||Feb 5, 1998||Hanno Lutz Prof Dr Baumann||Production of blood-compatible material, for implants, containers etc.|
|EP0193510A1 *||Feb 25, 1986||Sep 3, 1986||Pharmacia Ab||Shaped article of hyaluronic acid and processes for its preparation|
|EP0233708A2 *||Jan 22, 1987||Aug 26, 1987||Precision-Cosmet Co., Inc.||Coated substrates|
|EP0804129A1 †||Jan 11, 1996||Nov 5, 1997||Allergan||Iol insertion apparatus and method for using same|
|EP1262200A2 *||Jun 1, 1995||Dec 4, 2002||Genzyme Corporation||Inhibition of platelet adherence and aggregation|
|EP2075014A2||May 27, 2003||Jul 1, 2009||Angiotech International Ag||Compositions and methods for coating medical implants|
|EP2644623A1||Mar 26, 2013||Oct 2, 2013||Genewel Co., Ltd||Implantation material comprising biocompatible polymer|
|EP2825203A4 *||Mar 11, 2013||Oct 14, 2015||Univ Colorado State Res Found||Glycosaminoglycan and synthetic polymer materials for blood-contacting applications|
|WO1997048435A1 *||Jun 19, 1997||Dec 24, 1997||Medtronic Inc||Flow-directed catheter system and method of use|
|WO1998046686A1 *||Apr 14, 1998||Oct 22, 1998||Fidia Advanced Biopolymers Srl||Coatings based on hyaluronic acid and the derivatives thereof for the protection of electronic parts from external agents|
|WO2007015761A2 *||Jul 14, 2006||Feb 8, 2007||Therese Andersen||Medical devices coated with a fast dissolving biocompatible coating|
|WO2009085548A2 *||Dec 4, 2008||Jul 9, 2009||Ethicon Inc||Coated tissue engineering scaffold|
|U.S. Classification||428/425.1, 424/78.27, 427/400, 525/54.2, 428/452, 8/115.61, 424/423, 525/54.22, 428/481, 424/78.17, 428/478.4, 428/507, 525/54.23, 524/29, 428/447|
|International Classification||A61L27/00, C08L75/00, A61L27/26, C08J7/14, C08G85/00, C08L101/00, A61L33/06, C08L27/00, C08F8/00, C08J7/04, C08L1/00, C08L67/00, C08G18/00, C08L23/00, C08L77/00, C08L5/08, C08J3/20|
|Cooperative Classification||Y10T428/31591, C08G85/004, C08F8/00, Y10T428/31772, A61L33/062, Y10T428/3188, A61L27/26, Y10T428/3179, Y10T428/31663|
|European Classification||A61L27/26, A61L33/06A, C08F8/00, C08G85/00L|
|Sep 28, 1984||AS||Assignment|
Owner name: BIOMATRIX, INC., 65 RAILROAD AVE., RIDGEFIELD, NJ
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNORS:BALAZS, ENDRE A.;LESHCHINER, ADOLF;REEL/FRAME:004306/0535
Effective date: 19831013
|Jun 11, 1985||DC||Disclaimer filed|
Effective date: 19850315
|Feb 14, 1986||AS||Assignment|
Owner name: CHEMICAL BANK, C/O NATIONAL EXPANSION GROUP, 277 P
Free format text: SECURITY INTEREST;ASSIGNOR:BIOMATRIX, INC.,;REEL/FRAME:004510/0873
Effective date: 19860204
|Aug 8, 1988||FPAY||Fee payment|
Year of fee payment: 4
|Sep 22, 1992||REMI||Maintenance fee reminder mailed|
|Feb 18, 1993||SULP||Surcharge for late payment|
|Feb 18, 1993||FPAY||Fee payment|
Year of fee payment: 8
|Aug 19, 1996||FPAY||Fee payment|
Year of fee payment: 12
|May 17, 2000||AS||Assignment|
|Oct 11, 2001||AS||Assignment|